Currently Recruiting

11 drug trials actively seeking PKD patients. Links go directly to ClinicalTrials.gov enrollment pages.

How to enroll in a clinical trial

Click the "View on ClinicalTrials.gov" link for any trial below to see eligibility criteria, locations, and contact information. Always discuss participation with your nephrologist first.

Drug Trials Enrolling Patients (11)

Click "View on ClinicalTrials.gov" for eligibility criteria, locations, and contact information

ABBV-CLS-628 Phase 2

Undisclosed mechanism; IV infusion every 4 weeks for 92 weeks

Calico Life Sciences / AbbVie ANCHOR 240 participants Est. completion: 2029-08
AZD1613 Phase 1

Human monoclonal antibody against PAPPA

AstraZeneca PIONEER-PKD 40 participants Est. completion: 2027-05
Bempedoic Acid Phase 2

ACLY inhibitor / AMPK activator

University of Vermont (DoD-funded) BEAT-PKD 120 participants Est. completion: 2029-09
Dapagliflozin Phase 3

SGLT2 inhibitor

University of Cologne STOP-PKD 420 participants Est. completion: 2030-05
GV-100 Phase 1

Undisclosed oral drug candidate developed for ADPKD.

Gilva Therapeutics First-in-Human SAD/MAD 80 participants Est. completion: 2027-03

Thiazide diuretic added to tolvaptan

University Medical Center Groningen HYDRO-PROTECT 300 participants Est. completion: 2030-07
JMKX003142 Phase 2

Oral small molecule

Jemincare Phase 2 ADPKD 135 participants Est. completion: 2027
Metformin Phase 3

AMPK activator

University of Queensland IMPEDE-PKD 1174 participants Est. completion: 2027
PYC-003 Phase 1

Peptide-oligonucleotide conjugate that blocks the miR-17 binding site on PKD1 mRNA, restoring polycystin-1 (PC1) production while leaving miR-17's other targets untouched. Delivered IV.

PYC Therapeutics First-in-Human PKD1 166 participants Est. completion: 2028-11
Rotigotine Phase 2

Dopamine D5 receptor agonist (transdermal patch)

University Hospital Rouen ETERNAL-PKD 120 participants Est. completion: 2030-07
Tirzepatide Phase 2

GLP-1/GIP dual receptor agonist

University of Colorado Denver Tirzepatide in Overweight ADPKD 126 participants Est. completion: 2027

Disclaimer: Enrollment links direct to ClinicalTrials.gov, where you can find full eligibility criteria and site locations. Meeting eligibility criteria does not guarantee enrollment. Always consult your nephrologist before participating in a clinical trial.

Stay Updated on PKD Research

Get notified when new drugs enter clinical trials, trial results are published, or approved treatments change.

No spam. Unsubscribe anytime.